Among 804 androgen receptor pathway inhibitor-experienced mCRPC patients, 459 patients (57.1%) received another androgen receptor pathway inhibitor as their index therapy and 192 (23.9%) received ...

Q: I was told I have an elevated level of some protein (troponin) in my blood and that means I had a heart attack. But I ...

During a live event, Nizar M. Tannir, MD and participants discussed their takeaways from trial data on recurrent RCC ...

Zanzalintinib and atezolizumab improved overall survival in metastatic colorectal cancer compared to regorafenib, with a median OS of 10.9 vs 9.4 months. The combination showed progression-free ...

Recent advancements in medical technology suggest that simple blood tests could significantly enhance early cancer detection.

The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence ...

Scientists have identified two enzymes that help prostate cancer cells grow, survive and resist treatment, paving the way for new treatments.

For many Tennesseans, biomarker tests are not covered by insurance, which ultimately prevents them from receiving personalized testing and treatment.

Turku, Finland-based immunotherapy developer Faron tested its lead asset in combination with azacitidine. First and second-phase data resulted in an 85% objective response rate and a 45% complete ...

Biomarkers identified in BriaCell’s Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3 study of Bria-IMT™ in ...

A USC-led team has developed an innovative way to predict blood pressure outcomes after bariatric surgery that outperforms ...